123 related articles for article (PubMed ID: 12848633)
1. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?
Bolling-Sternevald E; Lauritsen K; Talley NJ; Junghard O; Glise H
Aliment Pharmacol Ther; 2003 Jul; 18(1):117-24. PubMed ID: 12848633
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).
Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V
Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
5. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
Meineche-Schmidt V
Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
[TBL] [Abstract][Full Text] [Related]
6. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
Jones R; Crouch SL
Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
[TBL] [Abstract][Full Text] [Related]
7. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
8. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
[TBL] [Abstract][Full Text] [Related]
12. Epigastric pain in dyspepsia and reflux disease.
Vakil N
Rev Gastroenterol Disord; 2003; 3 Suppl 4():S16-21. PubMed ID: 14671510
[TBL] [Abstract][Full Text] [Related]
13. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
[TBL] [Abstract][Full Text] [Related]
14. Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?
Di Mario F; Ingegnoli A; Dal Bò N; Cavestro GM; Moussa AM; Cavallaro LG; Aragona G; Iori V; Pilotto A; Franzè A; Rugge M
Helicobacter; 2004 Feb; 9(1):92-4. PubMed ID: 15156910
[No Abstract] [Full Text] [Related]
15. [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
Buzás GM
Orv Hetil; 2004 Oct; 145(42):2141-5. PubMed ID: 15566071
[TBL] [Abstract][Full Text] [Related]
16. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Talley NJ; Vakil N; Ballard ED; Fennerty MB
N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
[TBL] [Abstract][Full Text] [Related]
17. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
Talley NJ; Riff DS; Schwartz H; Marcuard SP
Aliment Pharmacol Ther; 2001 Oct; 15(10):1603-11. PubMed ID: 11564000
[TBL] [Abstract][Full Text] [Related]
18. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.
Bolling-Sternevald E; Lauritsen K; Aalykke C; Havelund T; Knudsen T; Unge P; Ekström P; Jaup B; Norrby A; Stubberöd A; Melén K; Carlsson R; Jerndal P; Junghard O; Glise H
Scand J Gastroenterol; 2002 Dec; 37(12):1395-402. PubMed ID: 12523588
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
20. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin.
Bigard MA; Delchier JC; Riachi G; Thibault P; Barthelemy P
Aliment Pharmacol Ther; 1998 Apr; 12(4):383-8. PubMed ID: 9690730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
